Practical info
- No registration needed
- Follow the symposium live on this page
- Add your questions to the comments, you will need to fill in a name to add comments
- Add to your calendar
Programme
Opening remarks
Rosalind Hollingsworth, Sanofi Pasteur, United States of America
Burden of influenza diseases in people 65 years old and over
Thomas Weinke, Klinikum Ernst von Bergmann, Germany
High dose influenza vaccine: benefits for older adults
Marc Van Ranst, University of Leuven, Belgium
North America experience: high dose vaccine focus on long term care
Stefan Gravenstein, Case Western Reserve University, United States of America
Q&A and Closing Remarks with Thomas Weinke, Marc Van Ranst, Stefan Gravenstein
Rosalind Hollingsworth, Sanofi Pasteur, United States of America
At the occasion of the 7th ESWI Influenza Conference, virtual edition, 6-9 December 2020 Sanofi Pasteur is organizing a satellite symposium on 8 December 18:00 - 20:00 CET.
10 years of evidence using high dose influenza vaccine in people age 65 and older
Chair: Rosalind Hollingsworth, Sanofi Pasteur
Thank you for attending the ‘10 years of evidence using high dose influenza vaccine in people age 65 and older’ symposium. Here is the form to share your feedback!